These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 20796319)
1. Activation of voltage-gated KCNQ/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats. Xu W; Wu Y; Bi Y; Tan L; Gan Y; Wang K Mol Pain; 2010 Aug; 6():49. PubMed ID: 20796319 [TBL] [Abstract][Full Text] [Related]
2. Activation of peripheral KCNQ channels attenuates inflammatory pain. Hayashi H; Iwata M; Tsuchimori N; Matsumoto T Mol Pain; 2014 Feb; 10():15. PubMed ID: 24555569 [TBL] [Abstract][Full Text] [Related]
3. Suppression of KCNQ/M (Kv7) potassium channels in the spinal cord contributes to the sensitization of dorsal horn WDR neurons and pain hypersensitivity in a rat model of bone cancer pain. Cai J; Fang D; Liu XD; Li S; Ren J; Xing GG Oncol Rep; 2015 Mar; 33(3):1540-50. PubMed ID: 25592230 [TBL] [Abstract][Full Text] [Related]
4. The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation. Dost R; Rostock A; Rundfeldt C Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):382-90. PubMed ID: 15007538 [TBL] [Abstract][Full Text] [Related]
5. KCNQ2/3/5 channels in dorsal root ganglion neurons can be therapeutic targets of neuropathic pain in diabetic rats. Yu T; Li L; Liu H; Li H; Liu Z; Li Z Mol Pain; 2018; 14():1744806918793229. PubMed ID: 30027794 [TBL] [Abstract][Full Text] [Related]
6. Activation of KCNQ Channels Suppresses Spontaneous Activity in Dorsal Root Ganglion Neurons and Reduces Chronic Pain after Spinal Cord Injury. Wu Z; Li L; Xie F; Du J; Zuo Y; Frost JA; Carlton SM; Walters ET; Yang Q J Neurotrauma; 2017 Mar; 34(6):1260-1270. PubMed ID: 28073317 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of cystathionine-β-synthetase expression contributes to inflammatory pain in rat temporomandibular joint. Miao X; Meng X; Wu G; Ju Z; Zhang HH; Hu S; Xu GY Mol Pain; 2014 Feb; 10():9. PubMed ID: 24490955 [TBL] [Abstract][Full Text] [Related]
8. The pan-Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo. Hansen HH; Weikop P; Mikkelsen MD; Rode F; Mikkelsen JD Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):46-51. PubMed ID: 27377794 [TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of A-fiber-mediated excitatory transmission underlies the analgesic effects of KCNQ channel opening in the spinal dorsal horn. Oyama M; Watanabe S; Iwai T; Tanabe M Neuropharmacology; 2024 Aug; 254():109994. PubMed ID: 38750803 [TBL] [Abstract][Full Text] [Related]
10. Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder. Rode F; Svalø J; Sheykhzade M; Rønn LC Eur J Pharmacol; 2010 Jul; 638(1-3):121-7. PubMed ID: 20385123 [TBL] [Abstract][Full Text] [Related]
11. Suppression of KCNQ/M (Kv7) potassium channels in dorsal root ganglion neurons contributes to the development of bone cancer pain in a rat model. Zheng Q; Fang D; Liu M; Cai J; Wan Y; Han JS; Xing GG Pain; 2013 Mar; 154(3):434-448. PubMed ID: 23352759 [TBL] [Abstract][Full Text] [Related]
12. Kv7/KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release. Vervaeke K; Gu N; Agdestein C; Hu H; Storm JF J Physiol; 2006 Oct; 576(Pt 1):235-56. PubMed ID: 16840518 [TBL] [Abstract][Full Text] [Related]
13. KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for treating orofacial cold hyperalgesia. Abd-Elsayed AA; Ikeda R; Jia Z; Ling J; Zuo X; Li M; Gu JG Mol Pain; 2015 Jul; 11():45. PubMed ID: 26227020 [TBL] [Abstract][Full Text] [Related]
15. Activation of neuronal Kv7/KCNQ/M-channels by the opener QO58-lysine and its anti-nociceptive effects on inflammatory pain in rodents. Teng BC; Song Y; Zhang F; Ma TY; Qi JL; Zhang HL; Li G; Wang K Acta Pharmacol Sin; 2016 Aug; 37(8):1054-62. PubMed ID: 27264315 [TBL] [Abstract][Full Text] [Related]
16. Antinociceptive Efficacy of Retigabine and Flupirtine for Gout Arthritis Pain. Zhang F; Liu S; Jin L; Tang L; Zhao X; Yang T; Wang Y; Huo B; Liu R; Li H Pharmacology; 2020; 105(7-8):471-476. PubMed ID: 32062659 [TBL] [Abstract][Full Text] [Related]
17. The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat. Hansen HH; Ebbesen C; Mathiesen C; Weikop P; Rønn LC; Waroux O; Scuvée-Moreau J; Seutin V; Mikkelsen JD J Pharmacol Exp Ther; 2006 Sep; 318(3):1006-19. PubMed ID: 16775195 [TBL] [Abstract][Full Text] [Related]
18. Estradiol upregulates voltage-gated sodium channel 1.7 in trigeminal ganglion contributing to hyperalgesia of inflamed TMJ. Bi RY; Meng Z; Zhang P; Wang XD; Ding Y; Gan YH PLoS One; 2017; 12(6):e0178589. PubMed ID: 28582470 [TBL] [Abstract][Full Text] [Related]
19. Activation of KCNQ channels located on the skeletal muscle membrane by retigabine and its influence on the maximal muscle force in rat muscle strips. Zagorchev P; Apostolova E; Kokova V; Peychev L Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):439-46. PubMed ID: 26815201 [TBL] [Abstract][Full Text] [Related]
20. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. Tatulian L; Delmas P; Abogadie FC; Brown DA J Neurosci; 2001 Aug; 21(15):5535-45. PubMed ID: 11466425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]